2m 2m 2m 2m 2m 2m 2m
SANUWAVE HEALTH (SNWV)
NASDAQ
$15.60-$0.005 (-0.03%)
Price as of Jun 03, 2026 4:10 PM EDT- $141.6MMarket Cap
- -46.72%1-Year Change
- Medical DevicesIndustry
SANUWAVE HEALTH (SNWV)
$15.60-$0.005 (-0.03%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 44.1M +34.98% | 32.6M +59.99% | 20.4M +21.84% | 16.7M +28.69% | |
Cost of Revenue | 10.1M +24.72% | 8.1M +33.95% | 6.0M +39.34% | 4.3M -13.14% | |
Gross Profit | 34.0M +38.37% | 24.6M +70.93% | 14.4M +15.73% | 12.4M +54.67% | |
Sales and Marketing Expense | 7.4M +17.33% | 6.3M +29.09% | 4.9M -34.47% | 7.5M -13.00% | |
Research and Development Expense | -1.4M +101.04% | -673,000 +16.23% | -579,000 +2.12% | -567,000 -48.50% | |
Depreciation and Amortization Expense | 974,000 -14.93% | 1.1M +11.38% | 1.0M +7.98% | 952,000 +35.23% | |
Total Operating Expenses | 29.0M +51.70% | 19.1M +28.38% | 14.9M -30.24% | 21.4M -3.62% | |
Operating Profit | 4.9M -8.71% | 5.4M +1,103.15% | -540,000 -93.97% | -9.0M -36.70% | |
Interest Income | 5.8M +103.43% | 2.9M N/A | N/A N/A | N/A N/A | |
Interest Expense | -6.2M -49.72% | -12.4M -58.22% | -29.7M +132.83% | -12.8M +85.54% | |
Interest Income and Expense and Net | -438,000 -95.42% | -9.6M -67.82% | -29.7M +132.83% | -12.8M +85.54% | |
Total Nonoperating Income and Expense | 7.0M +118.92% | -36.8M +45.52% | -25.3M +1,786.71% | -1.3M -89.77% | |
Income before Taxes | 11.9M +137.96% | -31.3M +21.48% | -25.8M +150.73% | -10.3M -62.21% | |
Income Taxes | 86,000 +218.52% | 27,000 +575.00% | 4,000 +100.00% | 2,000 -92.86% | |
Extraordinary Items | 196,000 N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 11.8M +137.65% | -31.4M +21.56% | -25.8M +150.72% | -10.3M -62.24% | |
Net Income from Continuing Operations Applicable to Common | 11.8M +137.65% | -31.4M +21.56% | -25.8M +150.72% | -10.3M -62.24% | |
Basic EPS and Net Income | 1.38 +119.63% | -7.03 +23,333.33% | -0.03 +50.00% | -0.02 -60.00% | |
Diluted EPS and Net Income | 0.41 +105.83% | -7.03 +23,333.33% | -0.03 +50.00% | -0.02 -60.00% | |
Basic Weighted Average Shares | 8.6M +91.88% | 4.5M -99.44% | 793.9M +44.48% | 549.5M +6.00% | |
Diluted Weighted Average Shares | 9.1M +103.51% | 4.5M -99.44% | 793.9M +44.48% | 549.5M +6.00% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 12.0M +16.82% | 10.2M +469.67% | 1.8M +55.85% | 1.2M +86.27% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 12.0M +16.82% | 10.2M +469.67% | 1.8M +55.85% | 1.2M +86.27% | |
Total Current Assets | 24.6M +33.86% | 18.4M +88.03% | 9.8M +47.79% | 6.6M +50.45% | |
Accumulated Depreciation | 358,000 N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 2.0M +169.40% | 732,000 -21.96% | 938,000 +25.07% | 750,000 +12.28% | |
Total Long-Term Assets | 12.7M +8.48% | 11.7M -7.20% | 12.6M -4.69% | 13.3M +12,402.83% | |
Total Assets | 37.3M +23.98% | 30.1M +34.36% | 22.4M +12.80% | 19.9M +6.74% | |
Income Taxes Payable | 3.9M N/A | N/A N/A | N/A N/A | 28,000 0.00% | |
Total Short-Term Debt | 6.3M N/A | 0 -100.00% | 20.8M +24.66% | 16.7M +42.13% | |
Total Current Liabilities | 17.8M -57.85% | 42.3M -34.61% | 64.8M +7.59% | 60.2M +6.97% | |
Total Long-Term Debt | 15.7M N/A | N/A N/A | N/A N/A | 0 -100.00% | |
Total Long-Term Liabilities | 17.9M +3,540.94% | 491,000 -41.48% | 839,000 +20.55% | 696,000 -47.03% | |
Total Liabilities | 35.7M -16.60% | 42.8M -34.70% | 65.6M +7.74% | 60.9M +5.74% | |
Retained Earnings | -242.7M -3.47% | -251.4M +14.26% | -220.0M +13.29% | -194.2M +5.60% | |
Total Stockholders Equity | 1.6M +112.73% | -12.7M -70.55% | -43.2M +5.29% | -41.0M +5.27% | |
Total Shares Outstanding | 8.6M +0.53% | 8.5M -99.25% | 1.1B +107.85% | 548.7M +13.94% | |
Cash Flow | |||||
Cash from Operating Activities | 3.9M +57.88% | 2.5M +154.10% | -4.5M -73.57% | -17.2M +167.89% | |
Capital Expenditures | 1.9M +296.33% | 490,000 N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | 3.4M +800.61% | -490,000 -2,433.33% | 21,000 -93.67% | 332,000 +162.76% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -5.6M -187.93% | 6.4M +21.93% | 5.2M -70.02% | 17.4M +239.46% | |
Financials Ratio | |||||
Gross Margin | 77.11% +2.51% | 75.23% +6.84% | 70.41% -5.01% | 74.13% +20.19% | |
Operating Margin | 11.23% -32.37% | 16.60% +727.03% | -2.65% -95.05% | -53.47% -50.81% | |
Return on Assets | 35.02% +129.32% | -119.43% -2.14% | -122.05% +128.21% | -53.48% -59.15% | |
Return on Equity | -212.89% -289.65% | 112.25% +83.10% | 61.31% +138.16% | 25.74% -75.13% | |
Revenue Growth | 34.99% -41.68% | 59.99% +174.70% | 21.84% -23.87% | 28.69% -87.00% | |
Current Ratio | 1.38 +217.58% | 0.43 +187.56% | 0.15 +37.36% | 0.11 +40.66% | |
Cash Ratio | 0.67 +177.13% | 0.24 +769.78% | 0.03 +44.79% | 0.02 +74.55% | |
Debt-to-Equity Ratio | 13.56 N/A | N/A N/A | N/A N/A | -0.41 +25.66% | |
Debt-to-Assets Ratio | 0.59 N/A | N/A N/A | N/A N/A | 0.84 +23.93% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow